Purdue Pharma, Canada
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Real World Evidence of the Efficacy and Safety of FOQUEST (NCT04152629) | Purdue Pharma, Canada | 2019-09-19 |
| Observational Study on the Use of Akynzeo® in Patients Receiving HEC (NCT03649230) | Purdue Pharma, Canada | 2018-10-03 |
| PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT03618030) | Purdue Pharma, Canada | 2018-08-21 |
Track Purdue Pharma, Canada automatically
Every clearance here is in the API, with alerts when new ones post.